Back to 
State Street Corp.
State Street Corp.
VIVO
Showing 0 of 15 quarters
Position history for State Street Corp.'s holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, State Street held 1,578,349 shares of VIVO (Meridian Bioscience), worth $52.4M. State Street's 13F filings listed VIVO from Q3 2019 to Q4 2022, 14 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.